Form 4 for TMO Thermo Fisher Scientific
Accepted 2025-11-12 00:00:00 ET · period of report 2025-11-10 · accession 0000097745-25-000163 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-11-12 | 2025-11-10 | TMO | Pettiti Gianluca | EVP | S - Sale+OE | $580.00 | -2,975 | 21.2K | -12% | -$1.73M |
| DM | 2025-11-12 | 2025-11-10 | TMO | Pettiti Gianluca | EVP | M - OptEx | $284.26 | +2,975 | 23.4K | +15% | +$845.7K |
| DM | 2025-11-12 | 2025-11-10 | TMO | Pettiti Gianluca | EVP | M - OptEx | $0.00 | -2,975 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-10 | S | D | 725 | $580.00 | 21,152.22 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-10 | M | A | 725 | $253.99 | 21,877.22 | D | — | — | |
| 3 | Common | Common Stock | 2025-11-10 | S | D | 2,250 | $580.00 | 21,152.22 | D | — | — | |
| 4 | Common | Common Stock | 2025-11-10 | M | A | 2,250 | $294.02 | 23,402.22 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-11-10 | M | D | 2,250 | $0.00 | 0 | D | $294.02 · — to 2026-09-05 | 2,250 Common Stock | (F3) The option vested in four equal installments on September 5, 2020, 2021, 2022, and 2023. |
| 6 | Derivative | Stock Option (Right to Buy) | 2025-11-10 | M | D | 725 | $0.00 | 0 | D | $253.99 · — to 2026-02-26 | 725 Common Stock | (F2) The option vested in four equal installments on February 26, 2020, 2021, 2022 and 2023. |